City
Epaper

Fapon Biotech announces chemiluminescence one-stop solution strategy in India at Medical Fair India 2023

By ANI | Updated: April 27, 2023 17:45 IST

New Delhi [India], April 27 (/PRNewswire): Fapon Biotech Inc. (Fapon Biotech, or the Company), a global leading IVD enterprise, ...

Open in App

New Delhi [India], April 27 (/PRNewswire): Fapon Biotech Inc. (Fapon Biotech, or the Company), a global leading IVD enterprise, has announced its innovative chemiluminescence one-stop solution strategy at the 28th edition of Medical Fair India.

Fapon chemiluminescence one-stop solution is designed to provide a complete range of chemiluminescence products and services, consisting of different levels of fully automatic chemiluminescence analyzers with open system platforms, reagent development support, as well as high quality core raw material in bulk production. Fapon Biotech aims to help local IVD partners quickly extend their product portfolio and streamline their production processes, as well as accelerate their business in the chemiluminescence immunoassay industry.

During the fair, Fapon Biotech has showcased a series of high performance automatic chemiluminescence analyzers: Shine i1000, the smallest fully automatic chemiluminescence immunoassay analyzer, and Shine i2000, the compact yet robust and large capacity analyzer. Fapon Biotech has developed a rich portfolio of over hundred chemiluminescence immunoassay reagents, including biomarkers for tumor, thyroid, infectious disease, cardiac, inflammation, etc.

Over the past fifteen years, Fapon Biotech has fostered partnerships with many top notch Indian IVD compes. It has contributed to more than half of the IVD raw materials in the Indian market. Leveraging the advantages of IVD raw materials, the Company aims to be the preferred partner of chemiluminescence immunoassay product developments for Indian IVD manufacturers.

As a global leading IVD enterprise, Fapon Biotech Inc. (referred to as "Fapon Biotech") focuses on the future needs and trends of biotechnology development and is committed to providing global diagnostic compes with high-performance IVD reagent raw materials, reagent services and innovative open instrument platforms.

Fapon Biotech expects to promote the development of the diagnosis industry with partners based on Fapon IVD Ecosystem, to achieve the mission of "empowering timely, accurate, and affordable diagnosis for all".

Media Contact :

Name: Tina Chen

Email:media@fapon.com

This story has been provided by PRNewswire. will not be responsible in any way for the content of this article. (/PRNewswire)

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Fapon Biotech Inc.Fapon biotechindiaNew DelhiThe new delhi municipal councilDelhi south-westIndiUk-indiaRepublic of indiaIndia indiaNew-delhi
Open in App

Related Stories

National‘Operation Sindoor Is India’s Policy Against Terrorism’: PM Narendra Modi’s Strong Message To Pak

National‘This Is Not the Era of War, but This Is Also Not the Era of Terrorism’: PM Narendra Modi On India-Pakistan Tensions (Watch Video)

National‘Pani Or Khoon Eksath Nahi Beh Sakte’: PM Modi On Suspension Of Indus Waters Treaty

NationalIndia-Pakistan Ceasefire: Donald Trump Claims the US Administration Stopped Nuclear War

NationalPM Narendra Modi's Address to The Nation Live Streaming: When and Where to Watch Prime Minister’s First Speech After India-Pakistan Ceasefire

Business Realted Stories

BusinessRising gold prices and global tariff tensions poised to push CPI higher in upcoming months: Report

BusinessIndia cuts coal imports by over 9% in FY25, saving USD 6.93 billion in forex

BusinessUdaipur: Traders urge PM Modi to ban marble imports from Turkey

BusinessPiyush Goyal takes stock of Invest India in bid to boost manufacturing sector

BusinessAirtel’s ₹199 Plan Vanishes from UPI Apps - Are Cheaper Recharges Coming to an End?